A subscription to JoVE is required to view this content. Sign in or start your free trial.

Research Article

A Standardized Nursing-Led Protocol Integrated Pain, Sleep, Medication Adherence, and Symptom Management in Postherpetic Neuralgia

115 views

⸱

September 11th, 2026

 ,  ,  ,  , 

In This Article

Summary

This prospective randomized controlled trial evaluated an eight-week standardized nursing-led protocol integrating pain assessment, sleep monitoring, medication-adherence support, and rule-based digital symptom monitoring for postherpetic neuralgia. Compared with usual care, the protocol was associated with greater improvement in pain, sleep, medication adherence, and symptom burden.

Abstract

Postherpetic neuralgia (PHN) is a persistent neuropathic pain condition after herpes zoster that frequently coexists with sleep disturbance, medication-related problems, and fluctuating symptoms. This study evaluated whether a standardized nursing-led protocol could improve multidimensional short-term outcomes beyond usual care. In this prospective, parallel-group randomized controlled trial, 128 adults with PHN were allocated 1:1 to usual care or usual care plus an eight-week protocol integrating structured pain assessment, sleep monitoring, medication-adherence support, and rule-based digital symptom monitoring. The primary outcome was the between-group difference in change in Numeric Rating Scale (NRS) pain score from baseline to Week 8. Secondary outcomes included Pittsburgh Sleep Quality Index (PSQI), MMAS-8 medication adherence, symptom burden, pain-related nocturnal awakenings, breakthrough pain, rescue analgesic use, adverse events, rule-based alerts, and nursing satisfaction. Week-8 data were available for 116 participants (57 usual care; 59 protocol). Mean NRS scores decreased from 7.19 ± 1.08 to 4.82 ± 1.53 in the usual-care group and from 7.28 ± 1.05 to 3.24 ± 1.28 in the protocol group. An NRS reduction of at least 2 points occurred in 49.1% and 76.3% of participants, respectively. The protocol group also showed larger improvements in PSQI, MMAS-8, symptom burden, and nocturnal awakenings, with fewer breakthrough-pain episodes and less rescue-analgesic use. These findings support further evaluation of the standardized nursing-led protocol in preregistered multicenter trials with intention-to-treat analyses and longer follow-up.

Introduction

Postherpetic neuralgia (PHN) is neuropathic pain that persists or recurs in the affected dermatome after herpes zoster caused by varicella-zoster virus. A threshold of at least 3 months after rash onset is commonly used to distinguish PHN from subacute herpetic neuralgia1. Peripheral nerve injury, ectopic activity, and central sensitization contribute to persistent pain, allodynia, and hyperalgesia2,3,4. PHN can substantially impair sleep and daily function, and sleep disruption may in turn amplify pain sensitivity5.

Access restricted. Please log in or start a trial to view this content.

Protocol

This prospective, parallel-group randomized controlled trial was conducted at the Department of Pain, Affiliated Hospital of Guizhou Medical University. The overall study conduct period extended from 2 January 2024 to 31 December 2025. The study was conducted in accordance with the Declaration of Helsinki. The study protocol was reviewed and approved by the Human Experimental Ethics Committee of Guizhou Medical University (Approval No. 2024 Ethics Review [154]). All participants provided written informed consent before enrollment. When caregiver assistance was required for study procedures, the participant’s own written informed consent remained mandatory and th....

Access restricted. Please log in or start a trial to view this content.

Results

Participant flow and analysis populations

Screening, enrollment, and follow-up completion

A total of 148 individuals were assessed for eligibility. Twenty were excluded before randomization: 8 did not meet diagnostic or symptom-severity criteria, 5 had a major coexisting pain condition, 4 did not complete the baseline assessment, and 3 declined participation. The remaining 128 participants were randomized equally to the usual-care a.......

Access restricted. Please log in or start a trial to view this content.

Discussion

In this prospective randomized trial, the standardized nursing-led protocol was associated with greater eight-week improvement in pain and several secondary outcomes than usual care. The difference in mean NRS reduction and the larger proportion achieving an absolute ≥2-point improvement support the primary clinical signal. The protocol did not replace physician-directed treatment; it standardized how nurses assessed symptoms, reinforced adherence, monitored sleep and adverse effects, and escalated predefined conce.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no competing interests.

Acknowledgements

The authors thank the participating patients and the clinical nursing staff of the Department of Pain, Affiliated Hospital of Guizhou Medical University, for their support in protocol implementation and data collection. This work was supported by the Affiliated Hospital of Guizhou Medical University Research Project (gyfyhl-2025-A20). During manuscript revision, OpenAI Codex was used to assist with language editing, organization of point-by-point responses, literature-supported wording, and preparation of revised figures. The authors retain full responsibility for the manuscript, analyses, and figures.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
10-item nursing satisfaction questionnaireStudy-developedStudy-specific instrumentWeek-8 nursing satisfaction assessment using a study-developed 10-item questionnaire
AmitriptylineHospital pharmacyNot applicablePhysician-prescribed neuropathic-pain treatment
DuloxetineHospital pharmacyNot applicablePhysician-prescribed neuropathic-pain treatment
Electronic data-capture systemAffiliated Hospital of Guizhou Medical UniversityInstitutional study systemDe-identified case-report data collection and management
GabapentinHospital pharmacyNot applicablePhysician-prescribed neuropathic-pain treatment
Mobile follow-up platformInstitutional study systemStudy-specific mobile follow-up interfaceDaily symptom entry and rule-based alert generation
Morisky Medication Adherence Scale (MMAS-8)Donald E. Morisky / authorized licensorNot applicableMedication-adherence assessment using the 8-item Morisky Medication Adherence Scale
Numeric Rating Scale (NRS)Not applicableNot applicable0–10 verbal/numeric scale; Pain-intensity assessment
PregabalinHospital pharmacyNot applicablePhysician-prescribed neuropathic-pain treatment
Pittsburgh Sleep Quality Index (PSQI)University of Pittsburgh / authorized sourceStandard PSQI instrumentSleep-quality assessment at baseline and Weeks 4 and 8
R softwareR Foundation for Statistical ComputingVersion 4.3.2; https://www.r-project.org/Statistical modeling
Rescue analgesic(s)Hospital pharmacyNot applicable; prescribed as clinically indicatedShort-course rescue treatment prescribed as clinically indicated
SPSS StatisticsIBM Corp.Version 27.0; https://www.ibm.com/products/spss-statisticsStatistical analysis
Structured Nursing Symptom ChecklistStudy-developedStudy-specific instrumentTen-item study-developed symptom-burden assessment
Paper symptom/pain diaryStudy-providedStudy-specific paper formUsed after discharge for evening NRS recording and daily sleep/symptom documentation when the mobile platform was not used
Sequentially numbered opaque sealed envelopesStudy teamNot applicableUsed for allocation concealment after eligibility and baseline assessment
Standardized case-report forms (CRFs)Study-developedStudy-specificUsed by trained research staff for baseline and follow-up data collection; paper forms were double-entered into the electronic database

References

  1. Gross GE et al. S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia. J Dtsch Dermatol Ges. 2020;18(1):55–78.
  2. Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: From mechanisms to treatment. Physiol Rev. 2021;101(1):259–301.
  3. Liu Q, Han J, Zhang X. Peripheral and central pathogenesis of postherpetic neuralgia. Skin Res Technol. 2024;30(8):e13867.
  4. Li Y, Jin J, Kang X, Feng Z. Identifying and evaluating biological markers of postherpetic neuralgia: A comprehensive review. Pain Ther. 2024;13(5):1095–1117.
  5. Ho A, Drew VJ, Kim T. What links sleep and neuropathic pain?: A literature review on th....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Pain ManagementSleep DisturbanceSymptom MonitoringNumeric Rating ScalePittsburgh Sleep QualityBreakthrough PainRescue Analgesic Use